SE398230B - Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan - Google Patents

Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan

Info

Publication number
SE398230B
SE398230B SE7402112A SE7402112A SE398230B SE 398230 B SE398230 B SE 398230B SE 7402112 A SE7402112 A SE 7402112A SE 7402112 A SE7402112 A SE 7402112A SE 398230 B SE398230 B SE 398230B
Authority
SE
Sweden
Prior art keywords
pyrrody
phenoxy
propanol
derivatives
amino
Prior art date
Application number
SE7402112A
Other languages
English (en)
Swedish (sv)
Inventor
K A Jaeggi
F Ostermayer
H Schroter
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH351873A external-priority patent/CH575921A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE398230B publication Critical patent/SE398230B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7402112A 1973-03-09 1974-02-18 Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan SE398230B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH351873A CH575921A5 (en) 1973-03-09 1973-03-09 Pyrrolylphenoxy propanolamine derivs - with anti-excitatory and adrenergic beta-receptor blocking activity
CH142774 1974-02-01

Publications (1)

Publication Number Publication Date
SE398230B true SE398230B (sv) 1977-12-12

Family

ID=25687625

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7402112A SE398230B (sv) 1973-03-09 1974-02-18 Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan

Country Status (19)

Country Link
US (1) US3984436A (es)
JP (1) JPS5821623B2 (es)
AR (2) AR204241A1 (es)
CA (1) CA1029732A (es)
DD (1) DD110493A5 (es)
DE (1) DE2409313C2 (es)
DK (1) DK153837C (es)
ES (1) ES424021A1 (es)
FR (1) FR2220266B1 (es)
GB (1) GB1465783A (es)
HK (1) HK1880A (es)
HU (1) HU169465B (es)
IE (1) IE38950B1 (es)
IL (1) IL44293A (es)
LU (1) LU69589A1 (es)
MY (1) MY8000225A (es)
NL (1) NL7402754A (es)
SE (1) SE398230B (es)
YU (5) YU39718B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2505423A1 (de) * 1975-02-08 1976-08-19 Merck Patent Gmbh Biphenylylaether und verfahren zu ihrer herstellung
US4096331A (en) * 1976-12-28 1978-06-20 A. H. Robins Company, Incorporated 1-Substituted-3-aminoethoxypyrrolidines
US4314943A (en) * 1977-07-13 1982-02-09 Mead Johnson & Company Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols
EP0265388A1 (de) * 1986-10-24 1988-04-27 Ciba-Geigy Ag Pyrrol-Derivate, therapeutische Mittel, die sie enthalten und ihre Verwendung
DE3714485A1 (de) * 1987-04-30 1988-11-17 Bayer Ag Pyrrolophenylalkanolamine und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
DE3727114A1 (de) * 1987-08-14 1989-02-23 Basf Ag Verfahren zur herstellung von pyrrolen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2986564A (en) * 1959-02-20 1961-05-30 Rips Richard Pyrrole compounds
GB1047927A (en) * 1964-03-09 1966-11-09 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
GB1465783A (en) 1977-03-02
YU286081A (en) 1983-09-30
YU42006B (en) 1988-04-30
YU286181A (en) 1983-09-30
FR2220266B1 (es) 1977-11-10
HK1880A (en) 1980-01-18
LU69589A1 (es) 1976-02-04
YU285881A (en) 1983-09-30
YU43506B (en) 1989-08-31
IL44293A (en) 1978-08-31
DK153837C (da) 1989-01-30
IE38950L (en) 1974-09-09
AR204241A1 (es) 1975-12-10
US3984436A (en) 1976-10-05
IE38950B1 (en) 1978-07-05
DE2409313C2 (de) 1986-10-16
DE2409313A1 (de) 1974-09-12
YU42027B (en) 1988-04-30
JPS5821623B2 (ja) 1983-05-02
NL7402754A (es) 1974-09-11
YU286281A (en) 1983-09-30
YU39718B (en) 1985-04-30
YU60374A (en) 1982-08-31
AR202495A1 (es) 1975-06-13
DK153837B (da) 1988-09-12
YU42005B (en) 1988-04-30
DD110493A5 (es) 1974-12-20
MY8000225A (en) 1980-12-31
ES424021A1 (es) 1977-01-01
HU169465B (es) 1976-11-28
FR2220266A1 (es) 1974-10-04
JPS49125356A (es) 1974-11-30
IL44293A0 (en) 1974-05-16
CA1029732A (en) 1978-04-18
AU6638174A (en) 1975-09-11

Similar Documents

Publication Publication Date Title
SE421319B (sv) Forfarande for framstellning av etbara polysackarider och polysackaridderivat
SE397523B (sv) Forfarande att framstella n-fenylpyrrolderivat med antiinflammatorisk och analgetisk verkan
SE7513606L (sv) Derivat av tetanustoxineta forfarande for deras framstellning och medel innehallande desamma
SE7513753L (sv) Forfarande for framstellning av 8,8-disubstituerade-6-metylergoliner och derivat derav
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
SE414633B (sv) Forfarande for framstellning av nya 4-(3-tert butylamino-propoxi)-2-metyl-indolderivat med terapeutisk verkan
SE398230B (sv) Forfarande for framstellning av 1-amino-3-/(pyrrody-1)-fenoxi/-2-propanol och derivat derav med terapeutisk verkan
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
SE7600343L (sv) Forfarande for framstellning av ferrocenderivat med terapeutisk verkan
SE396595B (sv) Forfarande for framstellning av difenylamin och derivat derav
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
SE415659B (sv) Forfarande for framstellning av basiskt substituerade xanten- och tioxantenderivat
SE409206B (sv) Forfarande for framstellning av kinoxalindionderivat med hypnotisk verkan
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
SE404022B (sv) Forfarande for framstellning av heterocykliska sulfoxider och sulfoner
SE394429B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan
SE7608115L (sv) Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan
SE417086B (sv) Forfarande for framstellning av 2-etylindan och 2-isopropylindan
SE7713839L (sv) Forfarande for framstellning av indanderivat med terapeutisk verkan
SE406586B (sv) Nytt forfarande for framstellning av 3-fenyl-indol-2-sarbonitril och derivat derav
SE409113B (sv) Foerfarande foer framstaellning av nya derivat av n-amino-3-fenylindoler med terapeutiska egenskaper
SE380526B (sv) Forfarande for framstellning av derivat av tienobensopyran och tiopyranobensopyran
SE394430B (sv) Forfarande for framstellning av indolylalkylaminer med terapeutisk verkan
SE385897B (sv) Forfarande for framstellning av bensoditianpyronderivat med terapeutisk verkan
SE399885B (sv) Forfarande for framstellning av salt av tryptofanderivat med sekretionshemmande och antispastisk verkan

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7402112-2

Effective date: 19910911

Format of ref document f/p: F